GeoVax Labs (GOVX) Earnings Date & Reports

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

GOVX is expected to report earnings to rise 6.19% to -102 cents per share on November 05

Q3'26

Est.

$-1.03

Q2'26

Beat

by $1.30

Q1'26

Missed

by $2.08

Q4'25

Missed

by $2.27

Q3'25

Missed

by $0.02

The last earnings report on July 27 showed earnings per share of -97 cents, beating the estimate of -226 cents. With 116.83K shares outstanding, the current market capitalization sits at 3.14M.

View a ticker or compare two or three

GOVX

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for GOVX